3
|
Garcia-Princival IMR, Princival JL, Dias da Silva E, de Arruda Lima SM, Carregosa JC, Wisniewski A, de Lucena CCO, Halwass F, Alves Franca JA, Ferreira LFGR, Hernandes MZ, Saraiva KLA, Peixoto CA, Baratte B, Robert T, Bach S, Gomes DC, Guedes Paiva PM, Marchand P, Rodrigues MDD, Gonçalves da Silva T. Streptomyces hygroscopicus UFPEDA 3370: A valuable source of the potent cytotoxic agent nigericin and its evaluation against human colorectal cancer cells. Chem Biol Interact 2020; 333:109316. [PMID: 33285127 DOI: 10.1016/j.cbi.2020.109316] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 10/15/2020] [Accepted: 11/04/2020] [Indexed: 12/24/2022]
Abstract
Streptomyces hygroscopicus UFPEDA 3370 was fermented in submerged cultivation and the biomass extract was partitioned, obtaining a fraction purified named EB1. After purification of EB1 fraction, nigericin free acid was obtained and identified. Nigericin presented cytotoxic activity against several cancer cell lines, being most active against HL-60 (human leukemia) and HCT-116 (human colon carcinoma) cell lines, presenting IC50 and (IS) values: 0.0014 μM, (30.0) and 0.0138 μM (3.0), respectively. On HCT-116, nigericin caused apoptosis and autophagy. In this study, nigericin was also screened both in vitro and in silico against a panel of cancer-related kinases. Nigericin was able to inhibit both JAK3 and GSK-3β kinases in vitro and its binding affinities were mapped through the intermolecular interactions with each target in silico.
Collapse
Affiliation(s)
| | - Jefferson Luiz Princival
- Departamento de Química Fundamental, Av. Jornalista Anibal Fernandes, s/n, Universidade Federal de Pernambuco, Recife, Pernambuco, 50740-560, Brazil
| | - Emmanuel Dias da Silva
- Departamento de Química Fundamental, Av. Jornalista Anibal Fernandes, s/n, Universidade Federal de Pernambuco, Recife, Pernambuco, 50740-560, Brazil
| | - Sandrine Maria de Arruda Lima
- Departamento de Antibióticos, Rua Prof. Moraes Rego, 1235, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Jhonattas Carvalho Carregosa
- Departamento de Química, Av. Marechal Rondon, s/n, Universidade Federal de Sergipe, Aracaju, Sergipe, 49100-000, Brazil
| | - Alberto Wisniewski
- Departamento de Química, Av. Marechal Rondon, s/n, Universidade Federal de Sergipe, Aracaju, Sergipe, 49100-000, Brazil
| | - Caio Cézar Oliveira de Lucena
- Departamento de Antibióticos, Rua Prof. Moraes Rego, 1235, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Fernando Halwass
- Departamento de Química Fundamental, Av. Jornalista Anibal Fernandes, s/n, Universidade Federal de Pernambuco, Recife, Pernambuco, 50740-560, Brazil
| | - José Adonias Alves Franca
- Departamento de Química Fundamental, Av. Jornalista Anibal Fernandes, s/n, Universidade Federal de Pernambuco, Recife, Pernambuco, 50740-560, Brazil
| | - Luiz Felipe Gomes Rebello Ferreira
- Laboratório de Química Teórica Medicinal (LQTM), Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Av. Prof. Artur de Sá - Cidade Universitária, Recife, PE, 50740-521, Brazil
| | - Marcelo Zaldini Hernandes
- Laboratório de Química Teórica Medicinal (LQTM), Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Av. Prof. Artur de Sá - Cidade Universitária, Recife, PE, 50740-521, Brazil
| | | | - Christina Alves Peixoto
- Laboratório de Ultraestrutura. Instituto Aggeu Magalhães (IAM), Fundação Oswaldo Cruz (FIOCRUZ), Recife, PE, Brazil; Instituto de Ciências e Tecnologia em Neuroimunomodulação (INCT-NIM), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, RJ, Brazil
| | - Blandine Baratte
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, F-29680, Roscoff, France; Sorbonne Université, CNRS, FR2424, Kinase Inhibitor Specialized Screening Facility - KISSf, Station Biologique, F-29688, Roscoff, France.
| | - Thomas Robert
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, F-29680, Roscoff, France; Sorbonne Université, CNRS, FR2424, Kinase Inhibitor Specialized Screening Facility - KISSf, Station Biologique, F-29688, Roscoff, France
| | - Stéphane Bach
- Sorbonne Université, CNRS, UMR8227, Integrative Biology of Marine Models Laboratory (LBI2M), Station Biologique de Roscoff, F-29680, Roscoff, France; Sorbonne Université, CNRS, FR2424, Kinase Inhibitor Specialized Screening Facility - KISSf, Station Biologique, F-29688, Roscoff, France.
| | - Dayene Correia Gomes
- Departamento de Bioquímica, Rua Prof. Moraes Rego, SN, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - Patricia Maria Guedes Paiva
- Departamento de Bioquímica, Rua Prof. Moraes Rego, SN, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - Pascal Marchand
- Universite de Nantes, Cibles et médicaments des infections et du cancer, IICiMed, EA 1155, Nantes, F-44000, France
| | - Maria do Desterro Rodrigues
- Departamento de Antibióticos, Rua Prof. Moraes Rego, 1235, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Teresinha Gonçalves da Silva
- Departamento de Antibióticos, Rua Prof. Moraes Rego, 1235, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil.
| |
Collapse
|
4
|
Suto T, Yanagita Y, Nagashima Y, Takikawa S, Kurosu Y, Matsuo N, Miura K, Simizu S, Sato T, Chida N. Unified Total Synthesis of Madangamine Alkaloids. BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 2019. [DOI: 10.1246/bcsj.20180334] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Takahiro Suto
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Yuta Yanagita
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Yoshiyuki Nagashima
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Shinsaku Takikawa
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Yasuhiro Kurosu
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Naoya Matsuo
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Kazuki Miura
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Siro Simizu
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Takaaki Sato
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| | - Noritaka Chida
- Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
| |
Collapse
|
10
|
Kevin Ii DA, Meujo DA, Hamann MT. Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opin Drug Discov 2009; 4:109-46. [PMID: 23480512 PMCID: PMC4896753 DOI: 10.1517/17460440802661443] [Citation(s) in RCA: 134] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND As multidrug-resistant (MDR) pathogens continue to emerge, there is a substantial amount of pressure to identify new drug candidates. Carboxyl polyethers, also referred to as polyether antibiotics, are a unique class of compounds with outstanding potency against a variety of critical infectious disease targets including protozoa, bacteria and viruses. The characteristics of these molecules that are of key interest are their selectivity and high potency against several MDR etiological agents. OBJECTIVE Although many studies have been published about carboxyl polyether antibiotics, there are no recent reviews of this class of drugs. The purpose of this review is to provide the reader with an overview of the spectrum of activity of polyether antibiotics, their mechanism of action, toxicity and potential as drug candidates to combat drug-resistant infectious diseases. CONCLUSION Polyether ionophores show a high degree of promise for the potential control of drug-resistant bacterial and parasitic infections. Despite the long history of use of this class of drugs, very limited medicinal chemistry and drug optimization studies have been reported, thus leaving the door open to these opportunities in the future. Scifinder and PubMed were the main search engines used to locate articles relevant to the topic presented in the present review. Keywords used in our search were specific names of each of the 88 compounds presented in the review as well as more general terms such as polyethers, ionophores, carboxylic polyethers and polyether antibiotics.
Collapse
Affiliation(s)
- Dion A Kevin Ii
- Professor of Pharmacy, Chemistry & Biochemistry University of Mississippi, National Center for Natural Products Research, CSO of Triton Biopharma, Department of Pharmacognosy, 407 Faser Hall, University, MS 38677, USA +1 662 915 5730 ; +1 662 915 6975 ;
| | | | | |
Collapse
|
12
|
Odoux C, Albers A, Amoscato AA, Lotze MT, Wong MKK. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer. Int J Cancer 2002; 97:458-65. [PMID: 11802207 DOI: 10.1002/ijc.1640] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Lung carcinoma is one of the most frequent causes of malignancy-related mortality in the world. Paclitaxel (PA) is an antineoplastic agent used in the treatment of non-small-cell lung cancer (NSCLC) and possesses a single-agent response rate approaching 25%. PA kills tumor cells by inducing both cellular necrosis and apoptosis. Fas and Trail receptors (DR4 and DR5) are TNF family members and act as death signal transduction proteins in the apoptosis cascade. Despite the importance of PA in lung cancer treatment, the function of Fas, DR4 and DR5 in PA-induced apoptosis, as well as the effect of their respective ligands FasL and TRAIL alone or in combination with PA, remains poorly understood. We show here that 10 microM PA induces a significant 10- to 57-fold increase in primary lung cancer cell apoptosis and is associated with 20-215% increases in caspase-3 activity in various NSCLC cell types. All the lung cancer cells express Fas, FasL, DR4 and DR5; however PA did not significantly modify their levels. We provide here the first time evidence that TRAIL is a potent inducer of apoptosis in multiple NSCLC cell lines. Noticeably, CH11, the Fas receptor cross-linking and the antagonistic anti-DR5 antibody enhance considerably the spontaneous apoptotic rate in 3 out of 5 cell types. The combination treatments, FasL+PA, TRAIL+PA or PA+anti-DR5 antibody, greatly enhance PA-apoptotic effect in most cell lines. These data suggest that the use of new combination treatment with PA and ligands targeting Fas or TRAIL receptors would be particularly efficacious.
Collapse
MESH Headings
- Antibodies, Monoclonal/pharmacology
- Antineoplastic Agents, Phytogenic/pharmacology
- Apoptosis/drug effects
- Apoptosis Regulatory Proteins
- Carcinoma, Non-Small-Cell Lung/pathology
- Caspase 3
- Caspases/biosynthesis
- Caspases/genetics
- Enzyme Induction/drug effects
- Fas Ligand Protein
- Gene Expression Regulation, Neoplastic/genetics
- Humans
- Lung Neoplasms/pathology
- Membrane Glycoproteins/metabolism
- Membrane Glycoproteins/pharmacology
- Paclitaxel/pharmacology
- RNA, Messenger/biosynthesis
- RNA, Neoplasm/biosynthesis
- Receptors, TNF-Related Apoptosis-Inducing Ligand
- Receptors, Tumor Necrosis Factor/antagonists & inhibitors
- Receptors, Tumor Necrosis Factor/immunology
- Receptors, Tumor Necrosis Factor/metabolism
- Receptors, Tumor Necrosis Factor/physiology
- TNF-Related Apoptosis-Inducing Ligand
- Tumor Cells, Cultured/drug effects
- Tumor Cells, Cultured/pathology
- Tumor Necrosis Factor-alpha/pharmacology
- fas Receptor/metabolism
Collapse
Affiliation(s)
- Christine Odoux
- Biological Therapeutics Laboratory, Biomedical Science Tower, University of Pittsburgh, Pittsburgh, PA 15213, USA.
| | | | | | | | | |
Collapse
|